Actual Medicinal Product (AMP) Enzalutamide 40mg tablets (Astellas Pharma Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: No special precautions for storage.
Provenance: This compatibility recommendation is derived from Xtandi 40mg tablets (Astellas Pharma Ltd).
Generic: Enzalutamide
Formulation: Enzalutamide 40mg tablets

Enzalutamide
- Enzalutamide 40mg tablets
  - Enzalutamide 40mg tablets (Astellas Pharma Ltd)